Dr. Kronn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
503 Grasslands Rd
Ste 200
Valhalla, NY 10595Phone+1 914-304-5280Fax+1 914-345-1755
Education & Training
- NYU Grossman School of MedicineResidency, Pediatrics, 1990 - 1996
- University of Dublin Trinity CollegeClass of 1989
Certifications & Licensure
- NY State Medical License 1993 - 2025
- CT State Medical License 1998 - 2024
- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors Castle Connolly, 2012-2014
- Top Doctors: New York Metro Area Castle Connolly, 2010-2014
- Join now to see all
Clinical Trials
- An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 21 citationsVariants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathyNorine Voisin, Rhonda E. Schnur, Sofia Douzgou, Susan M. Hiatt, Cecilie F. Rustad
American Journal of Human Genetics. 2021-05-06 - 17 citationsSafety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary...Priya S Kishnani, David Kronn, Anaïs Brassier, Alexander Broomfield, James Davison
Genetics in Medicine. 2023-02-01 - 139 citationsNewborn screening for Krabbe disease: the New York State model.Patricia K. Duffner, Michele Caggana, Joseph J. Orsini, David A. Wenger, Marc C. Patterson
Pediatric Neurology. 2009-04-01
Press Mentions
- Sanofi’s Next-Generation ERT Halts Progression of Pompe Disease in Patients, Interim Trial Data ShowFebruary 13th, 2020
- High Prices for Orphan Drugs Strain Families and InsurersJanuary 17th, 2017
- Sky-High Prices for Orphan Drugs Slam American Families and InsurersJanuary 17th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: